AB
ABBV
Market ClosedAbbVie Inc.
US
55.00K employees
CEO: Robert A. Michael
Founded: 2013
$251.52
+$0.00(+NaN%)
Market Cap
444.38B
Beta
0.31
52W Range
N/A
Dividend Yield
2.68%
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AbbVie's current price exceeds the PERT-weighted fair value by 25%, indicating potential overvaluation with high downside risk (83.3% scenarios below current price). Financial health reveals low profitability and growth amid high leverage, increasing volatility (40.19% coefficient of variation). Analyst targets and trading range suggest some optimism, but overall valuation signals elevated investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...
Fetching multi-methodology valuation ranges...
Explore ABBV
ABBV in the Healthcare
Mega Cap